Lipophilicity determination of psoralens used in therapy through solubility and partitioning: Comparison of theoretical and experimental approaches

Journal of Pharmaceutical Sciences

Volumn 85, Issue 4, 1996, Pages 387-392

  Said, A ^a   Makki, S ^a   Muret, P ^a   Rouland, J C ^a   Toubin, G ^a   Millet, J ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BERGAPTEN; METHOXSALEN; PSORALEN; TRIMETHYLPSORALEN;

ARTICLE; DRUG ABSORPTION; DRUG SOLUBILITY; LIPOPHILICITY; PARTITION COEFFICIENT; PREDICTION; SPECTROFLUOROMETRY; THEORY;

EID: 0029928230     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js950367f     Document Type: Article

References (49)

1. Morelock, M. M.; Choi L. L.; Bell G. L.; Wright J. L. J. Pharm. Sci. 1994, 83, 948-952.
2. Yalkowsky, S. H.; Banerjee, S. In Aqueous Solubility Methods of Estimation for Organic Compounds: Marcel Dekker: New York, 1992; pp 1-74.
3. Jackson, J. A.; Diliberto, J. J.; Birnbaum, L. S. Fund. Appl. Toxicol. 1993, 21, 334-344.
4. Mattie, D. R.; Bates, G. D.; Jepson, G. W.; Fischer, J. W.; McDougal, J. N. Fund. Appl. Toxicol. 1994, 22, 51-57.
5. Tanii, H.; Huang, J.; Ohyashiki, T.; Hashimoto, K. Neurotoxicol. Teratol. 1994, 16, 575-582.
6. Biagi, G. L.; Barbaro, A. M.; Sapone, A.; Recanatini, M. J. Chromatogr. A 1994, 662, 341-361.
7. Lafosse, M.; Marinier, P.; Joseph, B.; Dreux, M. J. Chromatogr. 1992, 623, 277-287.
8. Nowotnik, D. P.; Feld, T.; Nunn, A. D. J. Chromatogr. A 1993, 630, 105-115.
9. Noble, A. J. Chromatogr. A 1993, 642, 3-14.
10. De Bruijn, J.; Hermens, J. Environ. Toxicol. Chem. 1991, 10, 791-804.
11. Tsantili-Kakoulidou, A.; Fillipatos, E.; Todoulou, O.; Papadaki-Valiraki, A. J. Chromatogr. A 1993, 654, 43-52.
12. Chiou C. T.; Block, J. H. In Partition coefficient, determination and estimation; Dunn, W. J., III; Block, J. H., Eds.; Pergamon Press: New York, 1986; pp 37-57.
13. Hansch, C.; Leo A. In QSAR, fundamentals and applications in chemistry and biology; ACS Professional Reference Book Edition; American Chemical Society; Washington, DC, 1995; pp 125-168.
14. Takács-Novák, K.; Józan, M.; Szász, G. Int. J. Pharm. 1995, 113, 47-55.
15. Chessels, M.; Hawker, D. W.; Connel, D. W. Chemosphere 1991, 22, 1175-1190.
16. Parrish, J. A. In Psoralens in Cosmetics and Dermatology; Pergamon Press: New York, 1981; pp 17-30.
17. Hildebrand, J. H.; Prausnitz, J. M.; Scott, R. L. In Regular and Related Solutions. The Solubility of Gases, Liquids, and Solids; Van Nostrand Reinhold: New York, 1970; pp 85-165.
18. Yalkowsky, S. H.; Valvani, S. C.; Roseman, T. J. J. Pharm. Sci. 1983, 72, 866-870.
19. Rekker, R. F.; Mannhold, R. In Calculation of Drug Lipophilicity. The Hydrophobic Fragmental Constant Approach; VCH: New York, 1992; pp 14-61.
20. Meylan, W. M.; Howard, P. H. J. Pharm. Sci. 1995, 84, 83-92.
21. Makki, S.; Muret, P.; Bassignot, P.; Saïd, A. M.; Agache, P.; Millet, J. Proceedings of the Prediction of Percutaneous Penetration Conference; La Grande Motte, France, 4a, 1995, p 107.
22. Millet, J.; Muret, P.; Makki, S.; Bassignot, P. Proceedings of the 1st World Meeting APG/APV; Budapest, Hungary, 1995, pp 689-690.
23. Wu P. L.; Martin, A. J. Pharm. Sci. 1983, 72, 587-592.
24. Martin, A.; Wu, P. L.; Adjei, A.; Lindstrom, R. E.; Elworthy, H. J. Pharm. Sci. 1982, 72, 849-856.
25. Hansen, C. M.; Beerbower, A. In Solubility Parameters, Kirk Othmer Supplement Volume 2nd ed.; Van Nostrand Reinhold: New York, 1971; pp 889-910.
26. Lee, L.-H. J. Paint Technol. 1970, 42, 365-370.
27. Bustamante, P.; Escalera, B.; Martin, A.; Selles, E. J. Pharm. Pharmacol. 1993, 45, 253-257.
28. Fedors, R. F. Polym. Eng. Sci. 1974, 14, 147-154.
29. Hansen, C. M. J. Paint Technol. 1967, 39, 104-117.
30. Acree, W. E., Jr. In CRC Handbook of Chemistry and Physics, 67th ed.; Weast, R. C., Ed.; CRC Press: Boca Raton, FL, 1986-1987; pp c-666-c-676.
31. Prognon, P.; Simon, G.; Mahuzier, G. J. Chromatogr. 1983, 272, 193-199.
32. Dearden, J. C.; Bresnen, G. M. Quant. Struct. Act. Relat. 1988, 7, 133-144.
33. Leo, A.; Hansch, C.; Elkins, D. Chem. Rev. 1971, 71, 525-554.
34. Elgehausen, H.; D'hondt, C.; Fuerer, R. Pestic. Sci. 1981, 12, 219-227.
35. Da, Y.-Z.; Ito, K.; Fujiwara, H. J. Med. Chem. 1992, 35, 3382-3387.
36. Da, Y.-Z.; Yanagi, J.; Tanaka, K.; Fujiwara, H. Chem. Pharm. Bull. 1993, 41, 227-230.
37. Eadsforth, C. V.; Moser, P. Chemosphere 1983, 12, 1459-1475.
38. Maitani, Y.; Coutel-Egros, A.; Obata, Y.; Nagai, T. J. Pharm. Sci. 1993, 82, 416-420.
39. Yalkowsky, S, H. In Techniques of Solubilization of Drugs; Yalkowsky, S. H., Ed.; Marcel Dekker: New York, 1981; pp 1-14.
40. Liron, Z.; Cohen, S. J. Pharm. Sci. 1984, 73, 538-542.
41. Sloan, K. B.; Siver, K. G.; Koch, S. A. M. J. Pharm. Sci. 1986, 8, 744-748.
42. Beall, H.; Prankerd, R.; Sloan, K. Int. J. Pharm. 1994, 111, 223-233.
43. Stemple, N. R.; Watson, W. R. Acta Crystallogr. 1972, B28, 2485-2489.
44. Leo, A. J. Chem. Rev. 1993, 93, 1281-1306.
45. Leo, A. J. Chem. Pharm. Bull. 1995, 43, 512-513.
46. Dunn, W. J., III; Grigoras, S.; Johanson, E. In Determination and estimation of partition coefficients; Dune, W. J., III; Block, J. H., Eds.; Pergamon Press: New York, 1986; pp 21-36.
47. Personal Communication, June 1995.
48. De Wolff, F. A.; Thomas, T. V. Clin. Pharmacokinet. 1986, 11, 62-75.
49. Fischer, T.; Hartvig, P.; Bondesson, U. Acta Dermato-Venereol. 1979, 60, 177-179.